Cecka J Michael
UCLA Immunogenetics Center, Los Angeles, California, USA.
Clin Transpl. 2003:1-12.
The number of living donor kidney transplants reported to the OPTN/UNOS Registry more than doubled during the decade from 1992-2002, from 2,535 to 6,236, with the largest increases in transplants from offspring to their parents and from spouses and other genetically unrelated donors. Despite the rise in more HLA-incompatible living donors, 5-year graft survival rates among recipients transplanted between 1998-2002 were 78.5% and 77.5% for spouse and other unrelated donor grafts, respectively, and were comparable to that for one-haplotype-matched sibling transplants (80.7%). The number of deceased donor kidneys transplanted has remained static at less than 7,000 per year including about 850 (12%) from expanded criteria donors. The 5-year graft survival rate for ECD kidneys was 52.2% compared with 69.9% for standard criteria donor kidneys transplanted between 1998-2002. More than 1,000 patients aged 70-75 were transplanted during this period with 5-year graft survival rates of 50% or less when they received a deceased donor kidney. Nearly 40% of graft losses in this older group were due to death with a functioning graft, however, 25% reportedly died when their graft failed, suggesting a high rate of problems among older recipients. Early acute rejection episodes reduced both short- (10%+ at one year) and long-term (20-30% reduction in graft half-life) survival among first transplant recipients. However, when the serum creatinine level at discharge was <2.5 mg/dl, the early rejection had little if any effect on short- or long-term outcome. Time on dialysis before transplantation was an important determinant of first graft survival, with 5-year graft survival differences of about 10% comparing those transplanted within the first year with those who were on dialysis 4 or more years, regardless of the type of donor kidney. More than 60% of living donor kidney recipients were transplanted within 2 years of starting dialysis, compared with fewer than 20% of those who received a deceased donor kidney. Efforts to reduce cold ischemia times for ECD kidneys have been modestly successful, even before implementation of the new allocation system in November 2002. The percentage of ECD kidneys transplanted within 12 hours increased from 18% in 2001 to 25% in 2003 and the percentage with more than 24 hours of cold ischemia fell from 28% in 2001 to 20% in 2003. Prolonged ischemia of 42 hours was associated with a 5% lower 4-year survival rate of ECD kidneys compared with those transplanted within 12 hours.
向器官获取与移植网络/器官共享联合网络(OPTN/UNOS)登记处报告的活体供肾移植数量在1992年至2002年这十年间增加了一倍多,从2535例增至6236例,其中增加最多的是子女向父母以及配偶和其他基因不相关供体的移植。尽管更多HLA不匹配的活体供体有所增加,但1998年至2002年期间接受移植的受者中,配偶和其他不相关供体移植肾的5年移植肾存活率分别为78.5%和77.5%,与单倍型匹配的同胞移植(80.7%)相当。每年移植的 deceased donor kidneys数量一直维持在不到7000例,其中约850例(12%)来自扩大标准供体。1998年至2002年期间,ECD肾的5年移植肾存活率为52.2%,而标准标准供体肾的这一存活率为69.9%。在此期间,1000多名70至75岁的患者接受了移植,当他们接受 deceased donor kidney时,5年移植肾存活率为50%或更低。在这个老年组中,近40%的移植肾丢失是由于移植肾仍有功能时患者死亡,然而,据报道25%的患者在移植肾失败时死亡,这表明老年受者中存在较高的问题发生率。早期急性排斥反应会降低首次移植受者的短期(一年时超过10%)和长期(移植肾半衰期降低20 - 30%)存活率。然而,当出院时血清肌酐水平<2.5 mg/dl时,早期排斥反应对短期或长期结局几乎没有影响。移植前透析时间是首次移植肾存活的重要决定因素,将第一年接受移植的患者与透析4年或更长时间的患者相比,5年移植肾存活率相差约10%,无论供肾类型如何。超过60%的活体供肾受者在开始透析后2年内接受了移植,而接受 deceased donor kidney的受者这一比例不到20%。即使在2002年11月新分配系统实施之前,为减少ECD肾冷缺血时间所做的努力也取得了一定成功。12小时内移植的ECD肾比例从2001年的18%增至2003年的25%,冷缺血时间超过24小时的比例从2001年的28%降至2003年的20%。与12小时内移植的ECD肾相比,42小时的长时间缺血会使ECD肾的4年存活率降低5%。